Skip to content

VSee Health, Inc.: 10-K/A filed 2025-08-29

What VSee Health, Inc. reported in its annual report amendment filed 2025-08-29 (fiscal FY 2024): 51 published measures, 255 facts as tagged in accession 0001558370-25-011815.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-K/A (annual report amendment)
Filed
2025-08-29
Fiscal period
fiscal FY 2024
Accession
0001558370-25-011815 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VSee Health, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-12-3119,992,488USD
At 2024-09-3022,299,402USD
At 2024-06-3078,588,364USD
At 2023-12-31805,791USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-12-3120,010,976USD
At 2024-09-3021,366,274USD
At 2024-06-3025,484,398USD
At 2024-03-315,635,548USD
At 2023-12-315,105,311USD
At 2023-09-305,042,970USD
At 2023-03-313,923,102USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-12-31326,115USD
At 2023-12-31118,734USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-01-01 to 2024-12-31-57,702,015USD366
2024-07-01 to 2024-09-30-53,922,561USD92
2024-01-01 to 2024-09-30-54,493,913USD274
2024-04-01 to 2024-06-30-634,122USD91
2024-01-01 to 2024-06-30-571,352USD182
2024-01-01 to 2024-03-3162,770USD91
2023-01-01 to 2023-12-31-3,762,930USD365
2023-07-01 to 2023-09-30-189,756USD92
2023-01-01 to 2023-09-30-1,223,038USD273
2023-04-01 to 2023-06-30-503,320USD91
2023-01-01 to 2023-06-30-1,033,282USD181
2023-01-01 to 2023-03-31-529,962USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-12-31-5,789,542USD366
2023-01-01 to 2023-12-31-632,595USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2024-01-01 to 2024-12-3155,267USD366
2023-01-01 to 2023-12-314,335USD365

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2024-01-01 to 2024-12-3110,421,352USD366
2024-07-01 to 2024-09-303,354,437USD92
2024-01-01 to 2024-09-306,686,998USD274
2024-01-01 to 2024-06-303,332,561USD182
2024-01-01 to 2024-03-311,620,995USD91
2023-01-01 to 2023-12-315,765,889USD365
2023-07-01 to 2023-09-301,432,721USD92
2023-01-01 to 2023-09-304,281,712USD273
2023-04-01 to 2023-06-301,271,473USD91
2023-01-01 to 2023-06-302,848,991USD181
2023-01-01 to 2023-03-311,577,518USD90

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-01-01 to 2024-12-316,023,067USD366
2023-01-01 to 2023-12-31525,000USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-01-01 to 2024-12-31-26,144USD366
2023-01-01 to 2023-12-31-4,335USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-12-31-67,703,873USD
At 2024-09-30-64,495,771USD
At 2024-06-30-10,573,210USD
At 2024-03-31-9,939,087USD
At 2023-12-31-10,001,858USD
At 2023-09-30-7,443,298USD
At 2023-03-31-6,762,640USD
At 2022-12-31-6,238,928USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-01-01 to 2024-12-3110,213,036shares366
2023-01-01 to 2023-12-319,998,446shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-01-01 to 2024-12-3110,213,036shares366
2023-01-01 to 2023-12-319,998,446shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-01-01 to 2024-12-31-5.65USD/shares366
2024-07-01 to 2024-09-30-3.58USD/shares92
2024-01-01 to 2024-09-30-6.53USD/shares274
2024-04-01 to 2024-06-30-0.12USD/shares91
2024-01-01 to 2024-06-30-0.11USD/shares182
2024-01-01 to 2024-03-310.01USD/shares91
2023-01-01 to 2023-12-31-0.38USD/shares365
2023-07-01 to 2023-09-30-0.02USD/shares92
2023-01-01 to 2023-09-30-0.12USD/shares273
2023-04-01 to 2023-06-30-0.11USD/shares91
2023-01-01 to 2023-06-30-0.22USD/shares181
2023-01-01 to 2023-03-31-0.05USD/shares90

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-01-01 to 2024-12-31-5.65USD/shares366
2024-07-01 to 2024-09-30-3.58USD/shares92
2024-01-01 to 2024-09-30-6.53USD/shares274
2024-01-01 to 2024-06-30-0.11USD/shares182
2024-01-01 to 2024-03-310.01USD/shares91
2023-01-01 to 2023-12-31-0.38USD/shares365
2023-07-01 to 2023-09-30-0.02USD/shares92
2023-01-01 to 2023-09-30-0.12USD/shares273
2023-04-01 to 2023-06-30-0.11USD/shares91
2023-01-01 to 2023-06-30-0.22USD/shares181
2023-01-01 to 2023-03-31-0.05USD/shares90

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-01-01 to 2024-12-31-1,642,901USD366
2024-07-01 to 2024-09-308,802USD92
2024-01-01 to 2024-09-30-1,669,586USD274
2024-04-01 to 2024-06-30-1,678,388USD91
2024-01-01 to 2024-06-30-1,678,388USD182
2023-01-01 to 2023-12-311,838,490USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-12-31680,242USD
At 2023-12-313,657USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-12-31-62,150,845USD366
2024-07-01 to 2024-09-30-58,294,999USD92
2024-01-01 to 2024-09-30-59,123,462USD274
2024-04-01 to 2024-06-30-932,523USD91
2024-01-01 to 2024-06-30-828,463USD182
2024-01-01 to 2024-03-31104,060USD91
2023-01-01 to 2023-12-31-1,873,589USD365
2023-07-01 to 2023-09-30-353,066USD92
2023-01-01 to 2023-09-30-1,758,758USD273
2023-04-01 to 2023-06-30-689,837USD91
2023-01-01 to 2023-06-30-1,405,692USD181
2023-01-01 to 2023-03-31-715,855USD90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-12-313,020,967USD
At 2024-09-304,377,185USD
At 2024-06-303,075,953USD
At 2023-12-31802,134USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-12-3119,010,320USD
At 2024-09-3020,234,380USD
At 2024-06-3024,119,693USD
At 2023-12-315,105,311USD
At 2023-09-305,042,970USD
At 2023-03-313,923,102USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-12-314,283,397USD
At 2023-12-31416,798USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2024-12-314,916,694USD
At 2024-06-3061,591,904USD
At 2024-06-2461,591,904USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2024-12-3110,995,000USD
At 2023-12-310USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2024-12-311,716,370USD
At 2024-09-301,022,731USD
At 2024-06-30923,259USD
At 2023-12-31603,480USD
At 2023-01-01389,453USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-01-01 to 2024-12-3169,328,425USD366
2024-07-01 to 2024-09-3061,079,702USD92
2024-01-01 to 2024-09-3063,919,903USD274
2024-04-01 to 2024-06-301,709,519USD91
2024-01-01 to 2024-06-302,840,201USD182
2024-01-01 to 2024-03-311,130,682USD91
2023-01-01 to 2023-12-315,706,283USD365
2023-07-01 to 2023-09-301,307,388USD92
2023-01-01 to 2023-09-304,512,462USD273
2023-04-01 to 2023-06-301,487,023USD91
2023-01-01 to 2023-06-303,205,074USD181
2023-01-01 to 2023-03-311,718,051USD90

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2024-01-01 to 2024-12-317,177,580USD366
2024-07-01 to 2024-09-302,784,703USD92
2024-01-01 to 2024-09-304,796,441USD274
2024-04-01 to 2024-06-30776,996USD91
2024-01-01 to 2024-06-302,011,738USD182
2024-01-01 to 2024-03-311,234,742USD91
2023-01-01 to 2023-12-313,832,694USD365
2023-07-01 to 2023-09-30954,322USD92
2023-01-01 to 2023-09-302,753,704USD273
2023-04-01 to 2023-06-30797,186USD91
2023-01-01 to 2023-06-301,799,382USD181
2023-01-01 to 2023-03-311,002,196USD90

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2024-01-01 to 2024-12-313,243,772USD366
2024-07-01 to 2024-09-30569,734USD92
2024-01-01 to 2024-09-301,890,557USD274
2024-04-01 to 2024-06-30934,570USD91
2024-01-01 to 2024-06-301,320,823USD182
2023-01-01 to 2023-12-311,933,195USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-12-3116,297,190shares
At 2024-06-2514,692,820shares
At 2024-06-2414,692,820shares
At 2023-12-314,639,643shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-12-31326,115USD
At 2023-12-31118,734USD
At 2022-12-31230,664USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-12-3167,683,754USD
At 2024-09-3065,427,362USD
At 2024-06-3063,675,694USD
At 2023-12-316,027,153USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2024-12-31-18,488USD
At 2024-09-30933,128USD
At 2024-06-3053,103,966USD
At 2024-03-31-4,204,769USD
At 2023-12-31-4,299,520USD
At 2023-09-30-1,774,709USD
At 2023-03-31-1,102,545USD
At 2022-12-31-574,066USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2024-12-31379,585USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2024-12-31342,174USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2024-12-311,934,583USD
At 2023-12-31220,000USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2024-12-31899,387USD
At 2023-12-314,335USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2024-12-31219,145USD
At 2023-12-31678USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2024-12-3110,995,000USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2024-12-31446,826USD
At 2024-09-30466,737USD
At 2024-06-30260,789USD
At 2023-12-3179,920USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2024-12-31417,815USD
At 2023-12-31902,524USD
At 2023-09-301,057,622USD
At 2023-03-31889,643USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2024-12-313,248,433USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2024-12-3167,378USD
At 2024-09-3067,378USD
At 2024-06-3067,378USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-01-01 to 2024-12-31-59,344,916USD366
2024-07-01 to 2024-09-30-53,913,759USD92
2024-01-01 to 2024-09-30-56,163,499USD274
2024-04-01 to 2024-06-30-2,344,490USD91
2024-01-01 to 2024-06-30-2,249,740USD182
2024-01-01 to 2024-03-3194,750USD91
2023-01-01 to 2023-12-31-1,886,964USD365
2023-07-01 to 2023-09-30-411,007USD92
2023-01-01 to 2023-09-30-1,810,265USD273
2023-04-01 to 2023-06-30-681,686USD91
2023-01-01 to 2023-06-30-1,399,258USD181
2023-01-01 to 2023-03-31-717,572USD90

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2024-01-01 to 2024-12-31-57,702,015USD366
2024-07-01 to 2024-09-30-53,922,561USD92
2024-01-01 to 2024-09-30-54,493,913USD274
2024-04-01 to 2024-06-30-666,102USD91
2024-01-01 to 2024-06-30-571,352USD182
2024-01-01 to 2024-03-3194,750USD91
2023-01-01 to 2023-12-31-3,725,454USD365
2023-07-01 to 2023-09-30-177,291USD92
2023-01-01 to 2023-09-30-1,219,311USD273
2023-04-01 to 2023-06-30-507,291USD91
2023-01-01 to 2023-06-30-1,042,020USD181
2023-01-01 to 2023-03-31-534,729USD90

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-01-01 to 2024-12-316,553,961USD366
2024-07-01 to 2024-09-302,218,289USD92
2024-01-01 to 2024-09-302,997,525USD274
2024-04-01 to 2024-06-30568,469USD91
2024-01-01 to 2024-06-30779,236USD182
2024-01-01 to 2024-03-31210,767USD91
2023-01-01 to 2023-12-311,202,456USD365
2023-07-01 to 2023-09-30284,834USD92
2023-01-01 to 2023-09-301,012,393USD273
2023-04-01 to 2023-06-30386,346USD91
2023-01-01 to 2023-06-30727,559USD181
2023-01-01 to 2023-03-31341,213USD90

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2024-01-01 to 2024-12-3117,834USD366
2023-01-01 to 2023-12-31678USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2024-01-01 to 2024-12-311,105,000USD366
2023-01-01 to 2023-12-310USD365

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2024-01-01 to 2024-12-31211,459USD366
2024-07-01 to 2024-09-30115,385USD92
2024-01-01 to 2024-09-30466,530USD274
2024-04-01 to 2024-06-30341,835USD91
2024-01-01 to 2024-06-30351,145USD182
2023-01-01 to 2023-12-31191,323USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2024-01-01 to 2024-12-31504USD366
2023-01-01 to 2023-12-31-20,114USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-01-01 to 2024-12-312,805,929USD366
2024-07-01 to 2024-09-304,381,240USD92
2024-01-01 to 2024-09-302,959,963USD274
2024-04-01 to 2024-06-30-1,411,967USD91
2024-01-01 to 2024-06-30-1,421,277USD182
2023-01-01 to 2023-12-31-13,375USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2024-01-01 to 2024-12-31-1,679,404USD366
2024-01-01 to 2024-09-30-1,679,404USD274
2024-01-01 to 2024-06-30-1,679,404USD182
2023-01-01 to 2023-12-311,852,826USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2024-01-01 to 2024-12-31111,331USD366

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-12-311,094,190USD366
2024-01-01 to 2024-09-30228,904USD274
2024-01-01 to 2024-06-30-191,774USD182
2024-01-01 to 2024-03-3133,116USD91
2023-01-01 to 2023-12-31246,484USD365

Inspect the source

Entity
VSee Health, Inc. / CIK 0001864531
Captured
2026-09-21T17:39:21.273Z
SEC response SHA-256
6642e74f95af94f3060ba6cc0c814e9b3850bf810da50632789baa03a078bbe4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001864531.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))